![Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes](https://pub.mdpi-res.com/diabetology/diabetology-03-00007/article_deploy/html/images/diabetology-03-00007-g002.png?1644221977)
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
![Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41574-020-00443-4/MediaObjects/41574_2020_443_Fig1_HTML.png)
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology
![Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes | The Review of Diabetic Studies Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes | The Review of Diabetic Studies](https://diabeticstudies.org/sites/default/files/styles/large/public/RevDiabeticStud-9-4-289.png?itok=TdW0mXUa)
Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes | The Review of Diabetic Studies
![Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes](https://pub.mdpi-res.com/diabetology/diabetology-03-00007/article_deploy/html/images/diabetology-03-00007-g003.png?1644221977)
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
![Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes](https://www.frontiersin.org/files/Articles/369532/fimmu-09-01354-HTML-r1/image_m/fimmu-09-01354-g001.jpg)
Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes
![Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019) Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)](https://eje.bioscientifica.com/view/journals/eje/181/3/images/EJE-19-0291fig2.jpeg)
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)
![Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnri2705/MediaObjects/41577_2010_Article_BFnri2705_Fig1_HTML.jpg)